IBER.U

Ibere Pharmaceuticals Units, each consisting of one Class A ordinary share and one-half of one Redeemable Warrant
IBER.U

Delisted

IBER.U was delisted on the 1st of March, 2023.

Back to rankings

0 hedge funds and large institutions have $0 invested in Ibere Pharmaceuticals Units, each consisting of one Class A ordinary share and one-half of one Redeemable Warrant in 2023 Q1 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, 0 reducing their positions, and 10 closing their positions.

Upgrade to unlock
New
Increased
Maintained
Reduced
Closed

less funds holding

Funds holding: →

less capital invested

Capital invested by funds: $ → $

less first-time investments, than exits

New positions opened: | Existing positions closed:

Holders
–
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

No buyers this quarter

Top Sellers

1
-$1.75M
2
-$649K
3
-$573K
4
LCM
Landscape Capital Management
New Jersey
-$366K
5
TAM
Terrapin Asset Management
Florida
-$186K
Name Holding Trade Value Shares
Change 		Change in
Stake
SIA
1
Schechter Investment Advisors
Michigan
–
HF
2
HRT Financial
New York
–
Jane Street
3
Jane Street
New York
–
LCM
4
Landscape Capital Management
New Jersey
–
TAM
5
Terrapin Asset Management
Florida
–
WC
6
Wealthspring Capital
New York
–
Susquehanna International Group
7
Susquehanna International Group
Pennsylvania
–
SMA
8
Sage Mountain Advisors
Georgia
–
GCL
9
Glazer Capital LLC
New York
–
UBS Group
10
UBS Group
Switzerland
–